Literature DB >> 30232663

Association between Cystatin C and SVD in Chinese population.

Huang Guoxiang1, Lu Hui2, Zhou Yong3, Ji Xunming2, Chen Zhuo3.   

Abstract

Leukoaraiosis is an important clinical feature of cerebral small vessel disease. To date, there is no reliable biomarker to reflect the degree of cerebral small vessel disease and white matter damage. This study aimed to explore the relationship between cystatin C levels and the degree of white matter damage in order to assess whether cystatin C could serve as a biomarker for white matter damage. We conducted a retrospective analysis of 408 non-critically ill hospitalized patients. The included patients underwent related biochemical and cerebral magnetic resonance imaging examinations. The magnetic resonance imaging results were assessed using the Fazekas scale in fluid attenuation inversion recovery imaging. We analyzed the association of each risk factor (sex, age, blood glucose, blood lipid, and cystatin C) with the degree of white matter damage using univariate logistic and multivariate cumulative odds logistic regression (stepwise). Serum cystatin C concentration was closely associated with the degree of white matter damage (odds ratio = 2.14), while age, sex, and hypertension were associated with selective damage of brain white matter. Triglycerides and apolipoprotein A may have a protective effect against white matter damage.

Entities:  

Keywords:  Cerebral small vessel disease; Fazekas scale; Leukoaraiosis; cystatin C

Mesh:

Substances:

Year:  2018        PMID: 30232663     DOI: 10.1007/s10072-018-3577-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  32 in total

1.  Serum cystatin C concentration as a marker of renal dysfunction in the elderly.

Authors:  D Fliser; E Ritz
Journal:  Am J Kidney Dis       Date:  2001-01       Impact factor: 8.860

2.  Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study.

Authors:  David Singh; Mary A Whooley; Joachim H Ix; Sadia Ali; Michael G Shlipak
Journal:  Nephrol Dial Transplant       Date:  2007-01-08       Impact factor: 5.992

3.  White Matter Lesions Double the Risk of Post-Thrombolytic Intracerebral Hemorrhage.

Authors:  Sami Curtze; Elena Haapaniemi; Susanna Melkas; Satu Mustanoja; Jukka Putaala; Tiina Sairanen; Gerli Sibolt; Marjaana Tiainen; Turgut Tatlisumak; Daniel Strbian
Journal:  Stroke       Date:  2015-06-25       Impact factor: 7.914

4.  Kidney function and microstructural integrity of brain white matter.

Authors:  Sanaz Sedaghat; Lotte G M Cremers; Marius de Groot; Ewout J Hoorn; Albert Hofman; Aad van der Lugt; Oscar H Franco; Meike W Vernooij; Abbas Dehghan; M Arfan Ikram
Journal:  Neurology       Date:  2015-06-17       Impact factor: 9.910

5.  Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke.

Authors:  Jordi Jimenez-Conde; Alessandro Biffi; Rosanna Rahman; Allison Kanakis; Christi Butler; Shruti Sonni; Efi Massasa; Lisa Cloonan; Aaron Gilson; Karen Capozzo; Lynelle Cortellini; Angel Ois; Elisa Cuadrado-Godia; Ana Rodriguez-Campello; Karen L Furie; Jaume Roquer; Jonathan Rosand; Natalia S Rost
Journal:  Stroke       Date:  2010-02-04       Impact factor: 7.914

6.  Kidney function and cerebral small vessel disease in the general population.

Authors:  Saloua Akoudad; Sanaz Sedaghat; Albert Hofman; Peter J Koudstaal; Aad van der Lugt; M Arfan Ikram; Meike W Vernooij
Journal:  Int J Stroke       Date:  2015-03-05       Impact factor: 5.266

7.  Significant association between leukoaraiosis and metabolic syndrome in healthy subjects.

Authors:  K Park; N Yasuda; S Toyonaga; S M Yamada; H Nakabayashi; M Nakasato; T Nakagomi; E Tsubosaki; K Shimizu
Journal:  Neurology       Date:  2007-05-30       Impact factor: 9.910

Review 8.  Diabetes mellitus and white matter hyperintensity.

Authors:  Yoshiaki Tamura; Atsushi Araki
Journal:  Geriatr Gerontol Int       Date:  2015-12       Impact factor: 2.730

Review 9.  What are white matter hyperintensities made of? Relevance to vascular cognitive impairment.

Authors:  Joanna M Wardlaw; Maria C Valdés Hernández; Susana Muñoz-Maniega
Journal:  J Am Heart Assoc       Date:  2015-06-23       Impact factor: 5.501

10.  Cystatin C, a potential marker for cerebral microvascular compliance, is associated with white-matter hyperintensities progression.

Authors:  Woo-Jin Lee; Keun-Hwa Jung; Young Jin Ryu; Jeong-Min Kim; Soon-Tae Lee; Kon Chu; Manho Kim; Sang Kun Lee; Jae-Kyu Roh
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

View more
  3 in total

Review 1.  Cerebral Small Vessel Disease: Neuroimaging Features, Biochemical Markers, Influencing Factors, Pathological Mechanism and Treatment.

Authors:  Beida Ren; Ling Tan; Yuebo Song; Danxi Li; Bingjie Xue; Xinxing Lai; Ying Gao
Journal:  Front Neurol       Date:  2022-06-14       Impact factor: 4.086

2.  Association Cystatin C and Risk of Stroke in Elderly Patients With Obstructive Sleep Apnea: A Prospective Cohort Study.

Authors:  Xiaofeng Su; Yinghui Gao; Weihao Xu; JianHua Li; Kaibing Chen; Yan Gao; JingJing Guo; LiBo Zhao; Huanhuan Wang; Xiaoshun Qian; Junling Lin; Jiming Han; Lin Liu
Journal:  Front Neurosci       Date:  2021-12-15       Impact factor: 4.677

3.  Cystatin C predicts the risk of incident cerebrovascular disease in the elderly: A meta-analysis on survival date studies.

Authors:  Xin Zheng; Hong-da She; Qiao-Xin Zhang; Tong Si; Ku-Sheng Wu; Ying-Xiu Xiao
Journal:  Medicine (Baltimore)       Date:  2021-07-16       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.